Giana Frongillo
About Giana Frongillo
Giana Frongillo is a Research Associate II at the Broad Institute of MIT and Harvard, where she has worked since 2021, contributing to RNA and DNA sequencing protocols. She holds a Bachelor's degree in Forensic Biology from Western New England University and has experience in COVID-19 research and Next Generation Sequencing techniques.
Work at Broad Institute
Giana Frongillo has been employed at the Broad Institute of MIT and Harvard since 2020. She began her tenure as a Laboratory Technician, where she worked for six months before transitioning to the role of Research Associate I for seven months. In 2021, she advanced to the position of Research Associate II, where she has been contributing for three years. Her work primarily focuses on the development and optimization of protocols for RNA and DNA sequencing within the Microbial 'Omics Core.
Education and Expertise
Giana Frongillo earned her Bachelor's degree in Forensic Biology from Western New England University, completing her studies from 2016 to 2020. This educational background has provided her with a solid foundation in biological sciences, which she applies in her current research roles. Her expertise includes RNA-Taq Sequencing and various Next Generation Sequencing techniques, which are integral to her work at the Broad Institute.
Background
Giana Frongillo is based in Cambridge, Massachusetts, where she has built her career at the Broad Institute of MIT and Harvard. Her journey in the field of biological research began with her academic pursuits in Forensic Biology, leading to her current position. She has been involved in significant research projects, including a key role in a COVID-19 research initiative during the pandemic.
Research Contributions
In her role at the Broad Institute, Giana Frongillo has contributed to the development and optimization of protocols essential for RNA and DNA sequencing. Her involvement in the Microbial 'Omics Core has allowed her to work on various sequencing techniques, enhancing the capabilities of the research team. Her contributions have been particularly relevant in the context of COVID-19 research, showcasing her ability to adapt and respond to urgent scientific challenges.